Literature DB >> 22069244

Prediction of microvascular invasion of hepatocellular carcinoma: usefulness of peritumoral hypointensity seen on gadoxetate disodium-enhanced hepatobiliary phase images.

Kyung Ah Kim1, Myeong-Jin Kim, Hyae Min Jeon, Kyung Sik Kim, Jin-Sub Choi, Sang Hoon Ahn, Soon Joo Cha, Young Eun Chung.   

Abstract

PURPOSE: To determine whether peritumoral hypointensity seen on hepatobiliary phase images of preoperative gadoxetate disodium-enhanced magnetic resonance imaging (EOB-MRI) is useful for predicting microvascular invasion of hepatocellular carcinoma (HCC).
MATERIALS AND METHODS: This study was approved by the Institutional Review Board. In all, 104 HCC masses in 104 patients who had undergone EOB-MRI and liver surgery within 1 month after EOB-MRI were evaluated. Two radiologists independently recorded the presence of a peritumoral hypointensity on hepatobiliary phase. Interobserver agreement was assessed and consensus records were used. Tumor size was measured. A chi-square test and independent t-test were used for univariate analysis. Multiple logistic regression was performed to determine factors for predicting microvascular invasion. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of peritumoral hypointensity were calculated.
RESULTS: Sixty HCCs had microvascular invasion and 44 did not. Interobserver agreement in determining peritumoral hypointensity was excellent (κ = 0.83). By univariate analysis, peritumoral hypointensity and tumor size were significant for predicting microvascular invasion of HCC. On multiple logistic regression analysis, only peritumoral hypointensity was significant in predicting microvascular invasion of HCC (P = 0.013). The sensitivity, specificity, PPV, and NPV of peritumoral hypointensity were 38.3%, 93.2%, 88.5%, and 52.6%, respectively.
CONCLUSION: Peritumoral hypointensity on the hepatobiliary phase of EOB-MRI is not sensitive but has high specificity for predicting microvascular invasion of HCC.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22069244     DOI: 10.1002/jmri.22876

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  55 in total

Review 1.  Insight into hepatocellular carcinoma biology with gadoxetate disodium-enhanced MRI.

Authors:  Alexander Kagen; Kathryn Fowler; Claude B Sirlin
Journal:  Hepat Oncol       Date:  2013-12-20

Review 2.  Current status of imaging biomarkers predicting the biological nature of hepatocellular carcinoma.

Authors:  Norihide Yoneda; Osamu Matsui; Satoshi Kobayashi; Azusa Kitao; Kazuto Kozaka; Dai Inoue; Kotaro Yoshida; Tetsuya Minami; Wataru Koda; Toshifumi Gabata
Journal:  Jpn J Radiol       Date:  2019-02-02       Impact factor: 2.374

3.  Contrast-enhanced intraoperative ultrasound in the resection of colorectal liver metastases with intrabiliary growth.

Authors:  Junko Hiroyoshi; Suguru Yamashita; Mariko Tanaka; Akimasa Hayashi; Tetsuo Ushiku; Junichi Kaneko; Nobuhisa Akamatsu; Junichi Arita; Yoshihiro Sakamoto; Kiyoshi Hasegawa
Journal:  Clin J Gastroenterol       Date:  2018-04-09

4.  Ultrasound-based radiomics score: a potential biomarker for the prediction of microvascular invasion in hepatocellular carcinoma.

Authors:  Hang-Tong Hu; Zhu Wang; Xiao-Wen Huang; Shu-Ling Chen; Xin Zheng; Si-Min Ruan; Xiao-Yan Xie; Ming-de Lu; Jie Yu; Jie Tian; Ping Liang; Wei Wang; Ming Kuang
Journal:  Eur Radiol       Date:  2018-11-12       Impact factor: 5.315

5.  Pre-operative Microvascular Invasion Prediction Using Multi-parametric Liver MRI Radiomics.

Authors:  Giacomo Nebbia; Qian Zhang; Dooman Arefan; Xinxiang Zhao; Shandong Wu
Journal:  J Digit Imaging       Date:  2020-12       Impact factor: 4.056

6.  A non-smooth tumor margin on preoperative imaging predicts microvascular invasion of hepatocellular carcinoma.

Authors:  Tsung-Han Wu; Etsuro Hatano; Kenya Yamanaka; Satoru Seo; Kojiro Taura; Kentaro Yasuchika; Yasuhiro Fujimoto; Takashi Nitta; Masaki Mizumoto; Akira Mori; Hideaki Okajima; Toshimi Kaido; Shinji Uemoto
Journal:  Surg Today       Date:  2016-03-16       Impact factor: 2.549

Review 7.  JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan.

Authors:  Masatoshi Kudo; Osamu Matsui; Namiki Izumi; Hiroko Iijima; Masumi Kadoya; Yasuharu Imai; Takuji Okusaka; Shiro Miyayama; Kaoru Tsuchiya; Kazuomi Ueshima; Atsushi Hiraoka; Masafumi Ikeda; Sadahisa Ogasawara; Tatsuya Yamashita; Tetsuya Minami; Koichiro Yamakado
Journal:  Liver Cancer       Date:  2014-10       Impact factor: 11.740

8.  Magnetic resonance imaging with gadoxetic acid for local tumour progression after radiofrequency ablation in patients with hepatocellular carcinoma.

Authors:  Tae Wook Kang; Hyunchul Rhim; Jisun Lee; Kyoung Doo Song; Min Woo Lee; Young-Sun Kim; Hyo Keun Lim; Kyung Mi Jang; Seong Hyun Kim; Geum-Youn Gwak; Sin-Ho Jung
Journal:  Eur Radiol       Date:  2016-01-08       Impact factor: 5.315

9.  Gadoxetic acid-enhanced MRI as a predictor of recurrence of HCC after liver transplantation.

Authors:  Sunyoung Lee; Kyoung Won Kim; Woo Kyoung Jeong; Myeong-Jin Kim; Gi Hong Choi; Jin Sub Choi; Gi-Won Song; Sung-Gyu Lee
Journal:  Eur Radiol       Date:  2019-08-30       Impact factor: 5.315

Review 10.  CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features.

Authors:  Jin-Young Choi; Jeong-Min Lee; Claude B Sirlin
Journal:  Radiology       Date:  2014-10       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.